1-(烯丙氧基羰基)苯并三唑 | 114416-17-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并三唑类
• 中文名称: 1-(烯丙氧基羰基)苯并三唑
• 英文名称: 1-(allyloxycarbonyl)benzotriazole
• 英文别名: allyl 1H-benzo[d][1,2,3]triazole-1-carboxylate；prop-2-enyl benzotriazole-1-carboxylate
• CAS: 114416-17-0
• 化学式: C₁₀H₉N₃O₂
• 分子量: 203.2
• InChiKey: YOLMTYMZZHLITG-UHFFFAOYSA-N

物化性质

• 熔点：
  105.0-107.0 °C(Solv: dichloromethane (75-09-2); hexane (110-54-3))
• 沸点：
  325.4±35.0 °C(Predicted)
• 密度：
  1.27±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  57
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  双甘肽 、 1-(烯丙氧基羰基)苯并三唑 在 三乙胺 作用下， 以 水 、 乙腈 为溶剂， 反应 2.0h， 以90%的产率得到(2-{[(prop-2-en-1-yloxy)carbonyl]amino}acetamido)acetic acid
  参考文献：
  名称：

  Benzotriazole Reagents for the Syntheses of Fmoc-, Boc-, and Alloc-Protected Amino Acids

  摘要：

  在20℃下，稳定的三种苯并三唑（Fmoc-、Boc-和Alloc-苯并三唑）在三乙胺的存在下能够与多种氨基酸，包括未保护的丝氨酸和谷氨酸，反应，作为引入α-氨基保护基团的试剂，生成自由基肽和三肽杂质的无Fmoc-、Boc-和Alloc-保护氨基酸（产率77-94%）。通过在三乙胺存在下，用Fmoc-和Alloc-苯并三唑对甘氨酰甘氨酸进行N-酰化反应，制备了产率高达90%的Fmoc-和Alloc-甘氨酰甘氨酸二肽。通过HPLC分析，合成的N-保护氨基酸纯度高于99%。

  DOI：

  10.1055/s-0030-1261160
• 作为产物：
  描述：

  1-(三甲基硅基)苯并三氮唑 以 二氯甲烷 、 甲苯 为溶剂， 反应 1.0h， 生成 1-(烯丙氧基羰基)苯并三唑
  参考文献：
  名称：

  1-烷氧基羰基苯并三唑的热脱羧研究

  摘要：

  1-烷氧基羰基苯并三唑在热解过程中会损失二氧化碳；脱羧反应伴随着1-烷基苯并三唑和2-烷基苯并三唑的混合物的形成，在所有情况下，N -1异构体均高于N -2异构体。交叉实验中，加热等摩尔量的1-苄氧基羰基苯并三唑和1-（4-甲基苄氧基羰基）-5,6-二甲基苯并三唑几乎产生了所有交换产物，该实验支持所提出的分子间机理，用于该脱羧反应和形成1-和2-烷基苯并三唑。1-苯氧基羰基苯并三唑未观察到脱羧。

  DOI：

  10.1002/poc.610061007

文献信息

• Heterocyclic modulators of PKB
  申请人：ZENG Qingping

  公开号：US20090275592A1

  公开（公告）日：2009-11-05

  The invention relates to heterocyclic compounds of Formula I and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein. The invention also relates to the therapeutic use of such compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.

  本发明涉及一种公式I的杂环化合物及其组合物，其中变量具有本文所提供的定义，其在治疗由蛋白激酶B（PKB）介导的疾病方面具有用途。本发明还涉及这种化合物和组合物在治疗与异常细胞生长、癌症、炎症和代谢紊乱相关的疾病状态方面的治疗用途。
• [EN] HETEROCYCLIC MODULATORS OF PKB<br/>[FR] MODULATEURS HÉTÉROCYCLIQUES DE PKB
  申请人：AMGEN INC

  公开号：WO2009011880A3

  公开（公告）日：2009-04-02
• The synthesis of allyl- and allyloxycarbonyl-protected RNA phosphoramidites. Useful reagents for solid-phase synthesis of RNAs with base-labile modifications
  作者：Felicia M. Bogdan、Christine S. Chow

  DOI：10.1016/s0040-4039(98)00157-9

  日期：1998.4

  The synthesis of allyl-and allyloxycarbonyl (AOC)-protected RNA phosphoramidites is reported. The use of allyl and AOC groups allows the chemistry of solid-phase RNA synthesis to be expanded to include base-labile modified nucleosides, such as acetylcytidine. The allyl-and AOC-protective chemistry can be further expanded for the construction of RNAs on solid supports and affinity columns. (C) 1998 Elsevier Science Ltd. All rights reserved.
• β-Lactams fromD-Erythrose-Derived Imines: A Convenient Synthesis of 2,3-Diamino-2,3-dideoxy-D-mannonic-Acid Derivatives
  作者：Thomas Storz、Bruno Bernet、Andrea Vasella

  DOI：10.1002/(sici)1522-2675(19991215)82:12<2380::aid-hlca2380>3.0.co;2-p

  日期：1999.12.15

  The D-manno-configured N-anisylated beta-lactam 40, the beta-lactam carboxylic acids 4 and 43, and the corresponding phosphonic-acid isosters 49 and 50 have been synthesized from D-glucose in 8-10 steps, respectively None of these compounds exhibited a significant inhibitory activity in vitro against the sialidases of Vibrio cholerae, Salmonella typhimurium, Influenza A (N9), and Influenza B virus. Cycloaddition of the in situ generated imines derived from the D-erythroses 6, 16, and 17 with the ketene: from mesyloxyacetyl chloride (20) gave the 2-mesyloxy-D-hexono-1,3-lactams 25, 27a/b, 28a/b/c, and 29 in 23, 69, 57, and 90% yield, respectively (Scheme 3). Transformation of 27a/b and 29 (> 85%) to the corresponding azides, followed by oxidative N-deprotection, gave 30a/b (45%) and 34 (80%). Subsequent alkylation of the ring N-atom in 31a with benzyl bromoacetate and dibenzyl (triflyloxymethyl)phosphonate 46 gave the carboxylate 41 (77%) and the phosphonate 47 (55%; Schemes 4 and 5). Hydrogenolysis of 41 gave the beta-lactam amino acid 43, besides its hydrolysis product 44. Reductive N-acylation of the azido group in 41 (93%), followed by hydrogenolytic debenzylation, yielded the 2-trifluoroacetamido N-(carboxymethyl)-beta-lactam 4 (56%). Similarly, 47 gave the 2-trifluoroacetamide 48 (89%), and hence, the 2-amino-N-(phosphonoylmethyl)-beta-lactams 49 (40%) and 50, resulting from deacylation of 49 (14%). Aminolysis and carbamoylation of the protected beta-lactams 31a and 35 led to the 2,3-diamino-2,3-dideoxy-D-mannonamides 51 and 53, respectively (Scheme 6).
• HAYAKAWA, YOSHIHIRO;KATO, HISATOYO;NOBORI, TADAHITO;NOYORI, RYOJI;IMAI, J+, 14TH SYMP. NUCL. ACIDS CHEM., TOKUSHIMA, OCT. 30TH - NOV. 1ST, 1986, OXFO+
  作者：HAYAKAWA, YOSHIHIRO、KATO, HISATOYO、NOBORI, TADAHITO、NOYORI, RYOJI、IMAI, J+

  DOI：——

  日期：——